Market Digest Allstate Electronic Arts Packaging Corp of America Sector Moves in Focus AnheuserBusch InBev Shares Dip After Sales Miss Estimates Qualcomm Enters Budget PC Chip Market Amid Component Shortages Chinas Big Three Airlines Face Steep Challenges Amid Jet Fuel Costs and Rail Competition Kazatomproms ThirdQuarter Uranium Output Jumps 17 Reinforcing Supply Growth Trajectory Powell and Warsh A Historic Fed Coexistence Raises Questions About Policy Direction ANDG Q1 2026 Earnings Massive EPS Surprise of 834 Shatters Estimates Sysco Corporation SYY Q1 2026 Earnings Slight EPS Miss Amid Steady Operational Performance Arthur J Gallagher Co AJG Q1 2026 Earnings Modest EPS Miss Masks Steady Operational Progress PureTech Health plc PRTC Q4 2024 Earnings EPS Misses Estimates Amid Continued RD Investment CAG Q1 2026 Earnings EPS Misses Estimates Amidst Consumer Headwinds EXPE Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Resilient Travel Demand IsoEnergy Ltd ISOU Rallies Over 3 as Uranium Sector Sees Renewed Interest Sharps Technology Inc Warrant STSSW Slides 765 as Support and Resistance Converge at 004 Enovix Surges 666 Bulls Test Resistance After Strong Volume Move TROOPS Inc TROO Surges Over 6 Testing Key Resistance at 428 Revolution Medicines Inc RVMD Slips Slightly Amid Sector Rotation Key Support Levels Tested Kohls Struggles in Competitive Retail Landscape after Q1 2026 Earnings PPG Q1 2026 Earnings Earnings Beat Expectations Amid Operational Discipline Dune Acquisition Corporation II IPOD Edges Higher While Holding Above Key Support GPUS Q3 2025 Earnings Loss Per Share Reflects Operational Challenges Amid Data Center Expansion TOST Q1 2026 Earnings Profitability Surprise Drives Modest Stock Uptick KNDI Q2 2024 Earnings Profitability Achieved with EPS of 002 ATAT Q1 2026 Earnings Strong EPS Beat Amid Revenue Disclosure Absence LENZ Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Drives Costs Turn Therapeutics TTRX Q1 2026 Earnings Narrow EPS Miss Amid Modest Stock Gains Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges